Joshua Makower - Net Worth and Insider Trading
Joshua Makower Net Worth
The estimated net worth of Joshua Makower is at least $328 Million dollars as of 2024-04-24. Joshua Makower is the 10% Owner of Mirum Pharmaceuticals Inc and owns about 4,186,243 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $101 Million. Joshua Makower is the 10% Owner of AVEO Pharmaceuticals Inc and owns about 3,952,958 shares of AVEO Pharmaceuticals Inc (AVEO) stock worth over $59 Million. Joshua Makower is also the 10% Owner of Akouos Inc and owns about 4,294,207 shares of Akouos Inc (AKUS) stock worth over $57 Million. Besides these, Joshua Makower also holds Monte Rosa Therapeutics Inc (GLUE) , Ardelyx Inc (ARDX) , Trevi Therapeutics Inc (TRVI) , Inozyme Pharma Inc (INZY) , Marker Therapeutics Inc (MRKR) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Achaogen Inc (AKAOQ) , Metacrine Inc (MTCR) , Genocea Biosciences Inc (GNCAQ) , ARCA biopharma Inc (ABIO) . Details can be seen in Joshua Makower's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joshua Makower has not made any transactions after 2021-06-28 and currently still holds the listed stock(s).
Transaction Summary of Joshua Makower
Joshua Makower Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joshua Makower owns 31 companies in total, including Eargo Inc () , Metacrine Inc () , and Inozyme Pharma Inc () among others .
Click here to see the complete history of Joshua Makower’s form 4 insider trades.
Insider Ownership Summary of Joshua Makower
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Eargo Inc | 2020-10-20 | director & 10 percent owner | |
Metacrine Inc | 2020-09-18 | 10 percent owner | |
Inozyme Pharma Inc | 2020-07-28 | 10 percent owner | |
Genocea Biosciences Inc | 2020-07-24 | 10 percent owner | |
Annexon Inc | 2020-07-23 | 10 percent owner | |
Nkarta Inc | 2020-07-09 | 10 percent owner | |
Akouos Inc | 2020-06-30 | 10 percent owner | |
AVEO Pharmaceuticals Inc | 2020-06-19 | 10 percent owner | |
Trevi Therapeutics Inc | 2020-04-03 | 10 percent owner | |
Black Diamond Therapeutics Inc | 2020-01-29 | 10 percent owner | |
Regulus Therapeutics Inc | 2020-12-04 | 10 percent owner | |
Ardelyx Inc | 2016-07-18 | 10 percent owner | |
Mirum Pharmaceuticals Inc | 2019-07-22 | 10 percent owner | |
Nightstar Therapeutics PLC | 2019-06-07 | 10 percent owner | |
Millendo Therapeutics Inc | 2018-12-07 | 10 percent owner | |
Marker Therapeutics Inc | 2021-03-16 | 10 percent owner | |
Cascadian Therapeutics Inc | 2018-03-09 | 10 percent owner | |
ARCA biopharma Inc | 2018-02-26 | 10 percent owner | |
Achaogen Inc | 2016-12-19 | 10 percent owner | |
IRIDEX Corp | 2003-07-01 | director | |
Savara Inc | 2021-03-15 | 10 percent owner | |
Tempest Therapeutics Inc | 2018-12-07 | 10 percent owner | |
Reneo Pharmaceuticals Inc | 2021-04-08 | 10 percent owner | |
Verona Pharma PLC | 2021-01-01 | 10 percent owner | |
NeueHealth Inc | 2021-06-24 | 10 percent owner | |
Desktop Metal Inc | 2020-12-09 | 10 percent owner | |
Robinhood Markets Inc | 2021-07-29 | director & 10 percent owner | |
Berkshire Grey Inc | 2021-07-21 | 10 percent owner | |
Monte Rosa Therapeutics Inc | 2021-06-28 | 10 percent owner | |
Genocea Biosciences Inc | 2018-01-19 | 10 percent owner | |
Revolution Acceleration Acquisition Corp | 2021-07-21 | 10 percent owner |
Joshua Makower Latest Holdings Summary
Joshua Makower currently owns a total of 14 stocks. Among these stocks, Joshua Makower owns 4,186,243 shares of Mirum Pharmaceuticals Inc (MIRM) as of July 22, 2019, with a value of $101 Million and a weighting of 30.82%. Joshua Makower owns 3,952,958 shares of AVEO Pharmaceuticals Inc (AVEO) as of June 19, 2020, with a value of $59 Million and a weighting of 18.07%. Joshua Makower also owns 4,294,207 shares of Akouos Inc (AKUS) as of June 30, 2020, with a value of $57 Million and a weighting of 17.39%. The other 11 stocks Monte Rosa Therapeutics Inc (GLUE) , Ardelyx Inc (ARDX) , Trevi Therapeutics Inc (TRVI) , Inozyme Pharma Inc (INZY) , Marker Therapeutics Inc (MRKR) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Achaogen Inc (AKAOQ) , Metacrine Inc (MTCR) , Genocea Biosciences Inc (GNCAQ) , ARCA biopharma Inc (ABIO) have a combined weighting of 33.73% among all his current holdings.
Latest Holdings of Joshua Makower
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MIRM | Mirum Pharmaceuticals Inc | 2019-07-22 | 4,186,243 | 24.16 | 101,139,631 |
AVEO | AVEO Pharmaceuticals Inc | 2020-06-19 | 3,952,958 | 15.00 | 59,294,370 |
AKUS | Akouos Inc | 2020-06-30 | 4,294,207 | 13.29 | 57,070,011 |
GLUE | Monte Rosa Therapeutics Inc | 2021-06-28 | 7,692,298 | 5.50 | 42,307,639 |
ARDX | Ardelyx Inc | 2016-07-18 | 5,331,039 | 6.43 | 34,251,926 |
TRVI | Trevi Therapeutics Inc | 2020-04-03 | 5,937,998 | 2.71 | 16,091,975 |
INZY | Inozyme Pharma Inc | 2020-07-28 | 2,437,689 | 4.43 | 10,786,774 |
MRKR | Marker Therapeutics Inc | 2021-03-16 | 1,071,429 | 4.52 | 4,842,859 |
RGLS | Regulus Therapeutics Inc | 2020-12-04 | 645,106 | 2.25 | 1,451,489 |
EAR | Eargo Inc | 2020-10-20 | 326,001 | 2.57 | 837,823 |
AKAOQ | Achaogen Inc | 2016-12-19 | 5,215,128 | 0.03 | 130,378 |
MTCR | Metacrine Inc | 2020-09-18 | 3,060,527 | 0.00 | 4,285 |
GNCAQ | Genocea Biosciences Inc | 2020-07-24 | 10,376,936 | 0.00 | 0 |
ABIO | ARCA biopharma Inc | 2018-02-26 | 0 | 3.65 | 0 |
Holding Weightings of Joshua Makower
Joshua Makower Form 4 Trading Tracker
According to the SEC Form 4 filings, Joshua Makower has made a total of 1 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Mirum Pharmaceuticals Inc is the acquisition of 450,000 shares on July 22, 2019, which cost Joshua Makower around $7 Million.
According to the SEC Form 4 filings, Joshua Makower has made a total of 1 transactions in AVEO Pharmaceuticals Inc (AVEO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in AVEO Pharmaceuticals Inc is the acquisition of 1,428,571 shares on June 19, 2020, which cost Joshua Makower around $8 Million.
According to the SEC Form 4 filings, Joshua Makower has made a total of 1 transactions in Akouos Inc (AKUS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Akouos Inc is the acquisition of 588,235 shares on June 30, 2020, which cost Joshua Makower around $10 Million.
More details on Joshua Makower's insider transactions can be found in the Insider Trading History of Joshua Makower table.Insider Trading History of Joshua Makower
- 1
Joshua Makower Trading Performance
GuruFocus tracks the stock performance after each of Joshua Makower's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joshua Makower is 4.83%. GuruFocus also compares Joshua Makower's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joshua Makower within 3 months outperforms 15 times out of 32 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joshua Makower's insider trading performs compared to the benchmark.
Performance of Joshua Makower
Average Return
-34.21%
Outperforming Transactions
13%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 6.27 | 4.83 | 0.68 | -34.21 | -42.41 | -39.52 |
Relative Return to S&P 500(%) | 4.9 | 0.31 | -7.89 | -49.49 | -54.16 | -53.77 |
Joshua Makower Ownership Network
Ownership Network List of Joshua Makower
Ownership Network Relation of Joshua Makower
Joshua Makower Owned Company Details
What does Eargo Inc do?
Who are the key executives at Eargo Inc?
Joshua Makower is the director & 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .
Eargo Inc () Insider Trades Summary
Over the past 18 months, Joshua Makower made no insider transaction in Eargo Inc (). Other recent insider transactions involving Eargo Inc () include a net sale of 2,012 shares made by William Brownie , a net sale of 725 shares made by Adam Laponis , and a net sale of 92 shares made by Mark Thorpe .
In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,799 shares of Eargo Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,799 shares.
Eargo Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Eargo Inc Insider Transactions
Joshua Makower Mailing Address
Above is the net worth, insider trading, and ownership report for Joshua Makower. You might contact Joshua Makower via mailing address: 1212 Terra Bella Avenue, Mountain View Ca 94043.